96 results
424B3
INM
InMed Pharmaceuticals Inc.
27 Jun 24
Prospectus supplement
6:27pm
in or incorporated by reference in this prospectus supplement. We take no responsibility for, and can provide no assurance as to the reliability of, any … . There can be no assurance that we will be able to sell any of our common shares under this prospectus supplement or fully utilize the sales agreement
8-K
INM
InMed Pharmaceuticals Inc.
20 Mar 24
InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance
1:44pm
Rules. However, if the Company does appeal Nasdaq’s delisting determination to the Hearings Panel, there can be no assurance that such appeal would
8-K
EX-10.1
lokjgn
27 Oct 23
Entry into a Material Definitive Agreement
7:16pm
8-K
lzzpnw
22 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:29pm